Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;159(4):1678-1679.
doi: 10.1016/j.chest.2020.10.090. Epub 2021 Apr 6.

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019

Pedro David Delgado-López  1 , Luis Buzón-Martín  2 , Miguel Montero-Baladia  2 , Itziar Astigarraga  3
Affiliations
Comment

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019

Pedro David Delgado-López et al. Chest. 2021 Apr.
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Patel M, Dominguez E, Sacher D, Desai P, Chandar A, Bromberg M, Caricchio R, Criner GJ. Patel M, et al. Chest. 2021 Apr;159(4):1679. doi: 10.1016/j.chest.2020.11.035. Epub 2021 Apr 6. Chest. 2021. PMID: 34021999 Free PMC article. No abstract available.

Comment on

References

    1. Patel M., Dominguez E., Sacher D., et al. the Temple University COVID-19 Research Group. Etoposide as salvage therapy for cytokine storm due to coronavirus disease 2019. Chest. 2021;159(1):e7–e11. - PMC - PubMed
    1. Montero-Baladía M., Buzón L., Astigarraga I., et al. Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients. J Infect. 2020;81(3):452–482. - PMC - PubMed
    1. National Institutes of Health Clinical Center. Etoposide in patients with COVID-19 infection. NCT04356690. ClinicalTrials.gov. National Institutes of Health; 2020. Updated January 5, 2021. https://clinicaltrials.gov/ct2/show/NCT04356690.